Evoke Wealth’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.31M | Buy |
28,632
+4,758
| +20% | +$883K | 0.12% | 76 |
|
|
2025
Q1 | $5M | Buy |
23,874
+1,392
| +6% | +$292K | 0.13% | 71 |
|
|
2024
Q4 | $4M | Buy |
22,482
+2,556
| +13% | +$454K | 0.11% | 83 |
|
|
2024
Q3 | $3.94M | Buy |
+19,926
| New | +$3.94M | 0.11% | 82 |
|
|
2024
Q2 | – | Sell |
-19,748
| Closed | -$3.6M | – | 105 |
|
|
2024
Q1 | $3.6M | Buy |
+19,748
| New | +$3.6M | 0.11% | 84 |
|
|
2023
Q4 | – | Sell |
-21,105
| Closed | -$3.15M | – | 94 |
|
|
2023
Q3 | $3.15M | Buy |
21,105
+405
| +2% | +$60.4K | 0.11% | 91 |
|
|
2023
Q2 | $2.79M | Buy |
20,700
+222
| +1% | +$29.9K | 0.1% | 97 |
|
|
2023
Q1 | $3.26M | Buy |
20,478
+337
| +2% | +$53.7K | 0.12% | 85 |
|
|
2022
Q4 | $3.25M | Buy |
20,141
+39
| +0.2% | +$6.3K | 0.12% | 92 |
|
|
2022
Q3 | $2.7M | Buy |
20,102
+10
| +0% | +$1.34K | 0.11% | 89 |
|
|
2022
Q2 | $3.08M | Sell |
20,092
-65
| -0.3% | -$9.95K | 0.11% | 90 |
|
|
2022
Q1 | $3.27M | Sell |
20,157
-2,804
| -12% | -$455K | 0.11% | 93 |
|
|
2021
Q4 | $3.11M | Sell |
22,961
-1,290
| -5% | -$175K | 0.1% | 98 |
|
|
2021
Q3 | $2.62M | Sell |
24,251
-133
| -0.5% | -$14.3K | 0.1% | 106 |
|
|
2021
Q2 | $2.75M | Buy |
24,384
+5,638
| +30% | +$635K | 0.1% | 106 |
|
|
2021
Q1 | $2.03M | Buy |
18,746
+9,491
| +103% | +$1.03M | 0.09% | 113 |
|
|
2020
Q4 | $992K | Buy |
9,255
+743
| +9% | +$79.6K | 0.07% | 98 |
|
|
2020
Q3 | $746K | Buy |
8,512
+115
| +1% | +$10.1K | 0.06% | 103 |
|
|
2020
Q2 | $824K | Buy |
8,397
+3,712
| +79% | +$364K | 0.08% | 79 |
|
|
2020
Q1 | $357K | Sell |
4,685
-3,229
| -41% | -$246K | 0.05% | 125 |
|
|
2019
Q4 | $701K | Buy |
7,914
+394
| +5% | +$34.9K | 0.09% | 106 |
|
|
2019
Q3 | $569K | Buy |
+7,520
| New | +$569K | 0.07% | 138 |
|